IN150395B - - Google Patents

Info

Publication number
IN150395B
IN150395B IN830/DEL/78A IN830DE1978A IN150395B IN 150395 B IN150395 B IN 150395B IN 830DE1978 A IN830DE1978 A IN 830DE1978A IN 150395 B IN150395 B IN 150395B
Authority
IN
India
Application number
IN830/DEL/78A
Other languages
English (en)
Inventor
F Sciavolino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IN27/DEL/81A priority Critical patent/IN150407B/en
Publication of IN150395B publication Critical patent/IN150395B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN830/DEL/78A 1978-01-03 1978-11-20 IN150395B (US08087162-20120103-C00010.png)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN27/DEL/81A IN150407B (US08087162-20120103-C00010.png) 1978-01-03 1981-01-16

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86672278A 1978-01-03 1978-01-03
US05/937,640 US4180654A (en) 1978-01-03 1978-08-29 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate

Publications (1)

Publication Number Publication Date
IN150395B true IN150395B (US08087162-20120103-C00010.png) 1982-09-25

Family

ID=27127966

Family Applications (1)

Application Number Title Priority Date Filing Date
IN830/DEL/78A IN150395B (US08087162-20120103-C00010.png) 1978-01-03 1978-11-20

Country Status (28)

Country Link
US (1) US4180654A (US08087162-20120103-C00010.png)
JP (1) JPS5495585A (US08087162-20120103-C00010.png)
AT (1) AT364457B (US08087162-20120103-C00010.png)
AU (1) AU506684B2 (US08087162-20120103-C00010.png)
CH (1) CH639972A5 (US08087162-20120103-C00010.png)
CS (1) CS204042B2 (US08087162-20120103-C00010.png)
DD (1) DD141026A5 (US08087162-20120103-C00010.png)
DE (2) DE2900118A1 (US08087162-20120103-C00010.png)
DK (1) DK147943C (US08087162-20120103-C00010.png)
ES (2) ES476544A1 (US08087162-20120103-C00010.png)
FI (1) FI68058C (US08087162-20120103-C00010.png)
FR (1) FR2413403A1 (US08087162-20120103-C00010.png)
GB (1) GB2013181B (US08087162-20120103-C00010.png)
GR (1) GR72779B (US08087162-20120103-C00010.png)
HU (1) HU180276B (US08087162-20120103-C00010.png)
IE (1) IE47642B1 (US08087162-20120103-C00010.png)
IL (1) IL56363A (US08087162-20120103-C00010.png)
IN (1) IN150395B (US08087162-20120103-C00010.png)
IT (1) IT1109925B (US08087162-20120103-C00010.png)
LU (1) LU80747A1 (US08087162-20120103-C00010.png)
NL (1) NL176461C (US08087162-20120103-C00010.png)
NO (2) NO146711C (US08087162-20120103-C00010.png)
NZ (1) NZ189274A (US08087162-20120103-C00010.png)
PH (4) PH14745A (US08087162-20120103-C00010.png)
PL (2) PL117603B1 (US08087162-20120103-C00010.png)
PT (1) PT69014A (US08087162-20120103-C00010.png)
SE (2) SE447118B (US08087162-20120103-C00010.png)
YU (2) YU312278A (US08087162-20120103-C00010.png)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6211669Y2 (US08087162-20120103-C00010.png) * 1980-10-06 1987-03-19
JPS5848285U (ja) * 1981-09-26 1983-04-01 コナミ工業株式会社 テ−ブル型テレビゲ−ム機
US4429116A (en) * 1982-12-27 1984-01-31 Pfizer Inc. Alkylated oleandomycin containing compounds
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
JPS62240086A (ja) * 1986-04-12 1987-10-20 株式会社 エ−ス電研 遊技機の前面構造
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
YU55690A (en) * 1990-03-21 1990-12-31 Pliva Pharm & Chem Works Process for preparing oleandomycin oxime
CA2525455A1 (en) * 2003-05-13 2004-11-25 Glaxo Group Limited Novel 14 and 15 membered-ring compounds
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310992D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869445A (en) * 1973-05-03 1975-03-04 Abbott Lab 4{41 -O-sulfonyl erythromycin-9-O-oxime derivatives
US3884902A (en) * 1973-05-04 1975-05-20 Abbott Lab Sulfonyl derivatives of erythromycin
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US4063014A (en) * 1975-06-12 1977-12-13 Abbott Laboratories 4"-O-sulfonyl erythromycin-9-O-oxime derivatives
IE44509B1 (en) * 1976-03-03 1981-12-30 Pfizer Semi-synthetic oleandomycins
US4069379A (en) * 1976-07-08 1978-01-17 Pfizer Inc. Semi-synthetic oleandomycins
US4090017A (en) * 1977-02-04 1978-05-16 Pfizer Inc. 4-Deoxy-4-substituted amino derivatives of oleandomycin
US4085119A (en) * 1977-02-04 1978-04-18 Pfizer Inc. 4-Substituted amino derivatives of oleandomycin

Also Published As

Publication number Publication date
GR72779B (US08087162-20120103-C00010.png) 1983-12-05
NZ189274A (en) 1982-03-23
NO146711B (no) 1982-08-16
JPS5734280B2 (US08087162-20120103-C00010.png) 1982-07-22
PH14745A (en) 1981-11-20
PL118573B1 (en) 1981-10-31
JPS5495585A (en) 1979-07-28
LU80747A1 (fr) 1979-09-07
DD141026A5 (de) 1980-04-09
SE447118B (sv) 1986-10-27
SE448385B (sv) 1987-02-16
FR2413403A1 (fr) 1979-07-27
ATA2979A (de) 1981-03-15
SE8304417D0 (sv) 1983-08-15
PH15752A (en) 1983-03-18
IT1109925B (it) 1985-12-23
AU4298578A (en) 1979-07-12
GB2013181A (en) 1979-08-08
NO147716C (no) 1983-06-01
CH639972A5 (de) 1983-12-15
NO147716B (no) 1983-02-21
SE8304417L (sv) 1983-08-15
AU506684B2 (en) 1980-01-17
YU213982A (en) 1983-02-28
IT7919013A0 (it) 1979-01-02
NO146711C (no) 1982-11-24
YU312278A (en) 1983-01-21
FI68058B (fi) 1985-03-29
PH15626A (en) 1983-03-11
NO790006L (no) 1979-07-04
NO820613L (no) 1979-07-04
PL212593A1 (pl) 1979-08-27
ES476544A1 (es) 1979-12-01
FR2413403B1 (US08087162-20120103-C00010.png) 1982-07-23
PL117603B1 (en) 1981-08-31
IE790005L (en) 1979-07-03
IL56363A0 (en) 1979-03-12
ES482420A1 (es) 1980-09-01
SE7900028L (sv) 1979-07-04
DE2900118C2 (US08087162-20120103-C00010.png) 1987-09-17
HU180276B (en) 1983-02-28
DE2953969C2 (US08087162-20120103-C00010.png) 1987-09-03
DK147943B (da) 1985-01-14
FI790004A (fi) 1979-07-04
US4180654A (en) 1979-12-25
IL56363A (en) 1982-12-31
CS204042B2 (en) 1981-03-31
IE47642B1 (en) 1984-05-16
PT69014A (en) 1979-02-01
FI68058C (fi) 1985-07-10
DK507778A (da) 1979-07-04
AT364457B (de) 1981-10-27
NL176461C (nl) 1985-04-16
DE2900118A1 (de) 1979-07-05
DK147943C (da) 1985-08-05
GB2013181B (en) 1982-06-03
PH15439A (en) 1983-01-18
NL7900006A (nl) 1979-07-05

Similar Documents

Publication Publication Date Title
FR2415284B1 (US08087162-20120103-C00010.png)
FR2415657B1 (US08087162-20120103-C00010.png)
DE2825833C3 (US08087162-20120103-C00010.png)
FR2415544B1 (US08087162-20120103-C00010.png)
FR2414751B1 (US08087162-20120103-C00010.png)
FR2413403B1 (US08087162-20120103-C00010.png)
DE2930880C2 (US08087162-20120103-C00010.png)
DE2927416C2 (US08087162-20120103-C00010.png)
DE2929133C2 (US08087162-20120103-C00010.png)
DK141560C (US08087162-20120103-C00010.png)
DE2841030C2 (US08087162-20120103-C00010.png)
BG25921A1 (US08087162-20120103-C00010.png)
BG26009A1 (US08087162-20120103-C00010.png)
BG25902A1 (US08087162-20120103-C00010.png)
BG25898A1 (US08087162-20120103-C00010.png)
BG25897A1 (US08087162-20120103-C00010.png)
BG25918A1 (US08087162-20120103-C00010.png)
BG25889A1 (US08087162-20120103-C00010.png)
BG26013A1 (US08087162-20120103-C00010.png)
BG26012A1 (US08087162-20120103-C00010.png)
BG25879A1 (US08087162-20120103-C00010.png)
BG25922A1 (US08087162-20120103-C00010.png)
BG25940A1 (US08087162-20120103-C00010.png)
BG25875A1 (US08087162-20120103-C00010.png)
BG25874A1 (US08087162-20120103-C00010.png)